PL2644597T3 - Nowy sposób syntezy iwabradyny i jej farmaceutycznie dopuszczalnych soli addycyjnych z kwasem - Google Patents
Nowy sposób syntezy iwabradyny i jej farmaceutycznie dopuszczalnych soli addycyjnych z kwasemInfo
- Publication number
- PL2644597T3 PL2644597T3 PL13161193T PL13161193T PL2644597T3 PL 2644597 T3 PL2644597 T3 PL 2644597T3 PL 13161193 T PL13161193 T PL 13161193T PL 13161193 T PL13161193 T PL 13161193T PL 2644597 T3 PL2644597 T3 PL 2644597T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutically acceptable
- acid addition
- addition salts
- acceptable acid
- novel method
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- ACRHBAYQBXXRTO-OAQYLSRUSA-N ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 title 1
- 229960003825 ivabradine Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
- C07C55/07—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/22—All rings being cycloaliphatic the ring system containing eight carbon atoms, e.g. pentalene
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1252728A FR2988720B1 (fr) | 2012-03-27 | 2012-03-27 | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| EP13161193.1A EP2644597B1 (fr) | 2012-03-27 | 2013-03-26 | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2644597T3 true PL2644597T3 (pl) | 2016-06-30 |
Family
ID=47901913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13161193T PL2644597T3 (pl) | 2012-03-27 | 2013-03-26 | Nowy sposób syntezy iwabradyny i jej farmaceutycznie dopuszczalnych soli addycyjnych z kwasem |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US8835627B2 (pl) |
| EP (1) | EP2644597B1 (pl) |
| JP (1) | JP5580915B2 (pl) |
| KR (1) | KR101468398B1 (pl) |
| CN (1) | CN103450082B (pl) |
| AR (1) | AR090497A1 (pl) |
| AU (1) | AU2013201622C1 (pl) |
| BR (1) | BR102013007107A2 (pl) |
| CA (1) | CA2810060C (pl) |
| CL (1) | CL2013000820A1 (pl) |
| CY (1) | CY1117356T1 (pl) |
| DK (1) | DK2644597T3 (pl) |
| EA (1) | EA022774B1 (pl) |
| ES (1) | ES2568057T3 (pl) |
| FR (1) | FR2988720B1 (pl) |
| GE (1) | GEP20156369B (pl) |
| HR (1) | HRP20160262T1 (pl) |
| HU (1) | HUE028715T2 (pl) |
| JO (1) | JO3086B1 (pl) |
| MA (1) | MA34584B1 (pl) |
| MD (1) | MD4468C1 (pl) |
| MX (1) | MX2013002990A (pl) |
| MY (1) | MY185046A (pl) |
| NZ (1) | NZ608253A (pl) |
| PE (1) | PE20131318A1 (pl) |
| PL (1) | PL2644597T3 (pl) |
| PT (1) | PT2644597E (pl) |
| RS (1) | RS54652B1 (pl) |
| SA (1) | SA113340412B1 (pl) |
| SG (1) | SG193735A1 (pl) |
| SI (1) | SI2644597T1 (pl) |
| TW (1) | TWI457325B (pl) |
| UA (1) | UA113396C2 (pl) |
| UY (1) | UY34685A (pl) |
| WO (1) | WO2013144500A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2988720B1 (fr) * | 2012-03-27 | 2014-03-14 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3795683A (en) * | 1970-08-19 | 1974-03-05 | Hoffmann La Roche | 2,3,4,5-tetrahydro-1h-3-benzazepines |
| DE2639718C2 (de) * | 1976-09-03 | 1987-03-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | 1-[6,7-Dimethoxy-3,4-dihydro-2H-isochinolin-1-on-2-yl]-3-[N-methyl-N-(2-(3,4-dimethoxy-phenyl)-äthyl)-amino]-propan, dessen physiologisch verträgliche Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel |
| US4121924A (en) * | 1976-09-16 | 1978-10-24 | The International Nickel Company, Inc. | Alloy for rare earth treatment of molten metals and method |
| US4490369A (en) * | 1981-05-19 | 1984-12-25 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Benzazepine derivatives, their pharmaceutical compositions and method of use |
| FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
| FR2868777B1 (fr) * | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2870537A1 (fr) * | 2004-05-19 | 2005-11-25 | Servier Lab | Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| JP5198877B2 (ja) * | 2006-01-31 | 2013-05-15 | 株式会社エーピーアイ コーポレーション | ベンゾアゼピノン類の製造方法 |
| EP2460797A3 (en) * | 2006-11-30 | 2012-12-05 | Cadila Healthcare Limited | Process for preparation of ivabradine hydrochloride |
| WO2008132142A2 (en) * | 2007-04-27 | 2008-11-06 | Ucb Pharma S.A. | New heterocyclic derivatives useful for the treatment of cns disorders |
| FR2920773B1 (fr) * | 2007-09-11 | 2009-10-23 | Servier Lab | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2941695B1 (fr) * | 2009-02-04 | 2011-02-18 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2943668B1 (fr) * | 2009-03-31 | 2011-05-06 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
| FR2950343B1 (fr) * | 2009-09-18 | 2011-11-18 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2956401B1 (fr) * | 2010-02-17 | 2012-02-03 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| HUP1000245A2 (en) * | 2010-05-07 | 2011-11-28 | Richter Gedeon Nyrt | Industrial process for the production ivabradin salts |
| FR2984320B1 (fr) * | 2011-12-20 | 2013-11-29 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2984319B1 (fr) * | 2011-12-20 | 2013-12-27 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2988720B1 (fr) * | 2012-03-27 | 2014-03-14 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
-
2012
- 2012-03-27 FR FR1252728A patent/FR2988720B1/fr not_active Expired - Fee Related
-
2013
- 2013-03-14 MA MA35740A patent/MA34584B1/fr unknown
- 2013-03-14 CA CA2810060A patent/CA2810060C/fr not_active Expired - Fee Related
- 2013-03-14 PE PE2013000508A patent/PE20131318A1/es not_active Application Discontinuation
- 2013-03-14 NZ NZ608253A patent/NZ608253A/en not_active IP Right Cessation
- 2013-03-15 MX MX2013002990A patent/MX2013002990A/es active IP Right Grant
- 2013-03-18 AU AU2013201622A patent/AU2013201622C1/en not_active Ceased
- 2013-03-18 SG SG2013019583A patent/SG193735A1/en unknown
- 2013-03-18 UY UY0001034685A patent/UY34685A/es not_active Application Discontinuation
- 2013-03-19 JO JOP/2013/0077A patent/JO3086B1/ar active
- 2013-03-19 MY MYPI2013700443A patent/MY185046A/en unknown
- 2013-03-21 TW TW102110111A patent/TWI457325B/zh not_active IP Right Cessation
- 2013-03-24 SA SA113340412A patent/SA113340412B1/ar unknown
- 2013-03-25 CL CL2013000820A patent/CL2013000820A1/es unknown
- 2013-03-25 US US13/849,798 patent/US8835627B2/en not_active Expired - Fee Related
- 2013-03-25 GE GEAP201313040A patent/GEP20156369B/en unknown
- 2013-03-26 HU HUE13161193A patent/HUE028715T2/en unknown
- 2013-03-26 BR BRBR102013007107-2A patent/BR102013007107A2/pt not_active Application Discontinuation
- 2013-03-26 UA UAA201303751A patent/UA113396C2/uk unknown
- 2013-03-26 JP JP2013063204A patent/JP5580915B2/ja active Active
- 2013-03-26 PT PT131611931T patent/PT2644597E/pt unknown
- 2013-03-26 WO PCT/FR2013/050654 patent/WO2013144500A1/fr not_active Ceased
- 2013-03-26 SI SI201330161A patent/SI2644597T1/sl unknown
- 2013-03-26 KR KR1020130032073A patent/KR101468398B1/ko not_active Expired - Fee Related
- 2013-03-26 RS RS20160188A patent/RS54652B1/sr unknown
- 2013-03-26 AR ARP130100973A patent/AR090497A1/es unknown
- 2013-03-26 ES ES13161193.1T patent/ES2568057T3/es active Active
- 2013-03-26 DK DK13161193.1T patent/DK2644597T3/en active
- 2013-03-26 PL PL13161193T patent/PL2644597T3/pl unknown
- 2013-03-26 EA EA201300281A patent/EA022774B1/ru not_active IP Right Cessation
- 2013-03-26 EP EP13161193.1A patent/EP2644597B1/fr active Active
- 2013-03-27 CN CN201310101027.5A patent/CN103450082B/zh not_active Expired - Fee Related
- 2013-03-27 MD MDA20130016A patent/MD4468C1/ro not_active IP Right Cessation
-
2016
- 2016-03-14 HR HRP20160262TT patent/HRP20160262T1/hr unknown
- 2016-03-22 CY CY20161100243T patent/CY1117356T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL221306A0 (en) | Crystallization method and bioavailability | |
| EP2798159A4 (en) | ADVANCED ELECTRICAL TENSIONER-GENERATOR USING SUPERCRITICAL CO2 | |
| IL235425B (en) | History of lysine-glutamic acid di-peptide | |
| HUE064462T2 (hu) | Eljárás aceszulfám-kálium elõállítására | |
| HUE048141T2 (hu) | Eljárás a-fluor-akrilsav-észter elõállítására | |
| IL233945A0 (en) | A method for the production of modified anthranilic acid precursors | |
| SG10201705091YA (en) | METHOD FOR PRODUCING cis-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID DERIVATIVE, AND METHOD FOR PURIFYING cis-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID | |
| HRP20130368T1 (en) | New method for synthesising ivabradine and its added salts with a pharmaceutically acceptable acid | |
| ZA201404277B (en) | Process for making magnolol and derivatives thereof | |
| EP2792640A4 (en) | METHOD FOR THE PRODUCTION OF HIGH-PURITY CHLOROPOLYSILANE | |
| EP2751074A4 (en) | 5-SULPHISOPHTHALIC ACID SALTS AND PROCESS FOR THE PREPARATION THEREOF | |
| IL239136A0 (en) | A method for the production of derivatives of 3-mercapto-4-haloalkyl substituted 2-hydroxy-benzoic acid | |
| PL2364972T3 (pl) | Nowy sposób syntezy iwabradyny i jej soli addycyjnych | |
| SI2607353T1 (sl) | Nov postopek sintetize ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino | |
| ZA201304131B (en) | Process for producing nitric acid | |
| PL2644597T3 (pl) | Nowy sposób syntezy iwabradyny i jej farmaceutycznie dopuszczalnych soli addycyjnych z kwasem | |
| GB201223319D0 (en) | Process for producing lactic acid | |
| IL221258A0 (en) | Method for producing cyanoalkenylcyclopropanecarboxylic acid salt | |
| IL218764A0 (en) | Crystalline levofolinic acid and process for its preparation | |
| PL2607354T3 (pl) | Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym | |
| EP2810933A4 (en) | PROCESS FOR PREPARING A SOLID AMINO ACID | |
| EP2910545A4 (en) | PROCESS FOR PREPARING N, N-DIALKYLHOMOFARNESIC ACID AMID | |
| EP2750706A4 (en) | 2-HYDROXYHIPPURIC ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS AND USE | |
| IL226097A0 (en) | A process for the production of derivatives of 4-carbonyloxyquinoline | |
| GB201105988D0 (en) | Acid formation |